The Apixio Platform
More than 1.2 billion clinical documents are generated each year in the U.S., but there is very little analysis of that unstructured information. The Apixio Platform can mine textual data and combine its generated insights with available structured data to craft computable individual health profiles, or phenotypes. We analyze our assembled phenotypes in real-time using a flexible rules engine. This automates the execution of clinical guidelines, quality and risk measures, payment or reimbursement policies, and other operational and administrative rules, to support critical healthcare activities.
Apixio is the leader in creating and executing high performance AI algorithms for natural language processing in healthcare. Our proven machine learning and deep learning algorithms analyze unstructured data embedded in electronic health records, scanned notes, facsimiles, and handwritten notes to produce high quality predictions for measurement, care and discovery.
Our AI platform converts unstructured patient information into actionable data, so you can get a complete picture of healthcare. Our solutions support better decisions to deliver quality and affordable care.
Experience the Apixio difference firsthand
Looking to connect in person? We regularly host online webinars and sponsor dozens of trade shows and industry meetings nationwide.
Recent articles and news
SAN MATEO, Calif., OCTOBER 19, 2021—Apixio, Inc., the healthcare AI analytics company,…
During the pandemic, many Medicare ACOs experienced challenges related to the cost…
Apixio’s New Prospective Risk Adjustment Solutions Surface Actionable Insights to Improve Risk Capture & Clinical Guidance
Advanced AI technology analyzes Patients’ Longitudinal Record to Identify Care Gaps, Increase…
Healthcare Analytics Company Apixio Earns the Bay Area Top Workplaces Award for…